SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Travere Therapeutics Q3 2026 Earnings Call Begins

Travere Therapeutics' quarterly earnings call has begun.

TVTX
SquawkNews Desk

Travere Therapeutics's quarterly earnings call has just begun.Live earnings calls are not yet supported in the mobile app. To listen and follow along in real time, open TradingView website in your browser.

Related stories

Apple CFO Sees Memory Purchase Pricing Continuing to Rise Apple’s CFO said memory purchase pricing is continuing to increase. L impact | EQUITY | Nov 02, 2026, 10:40 PM UTC Apple CFO Says Memory Purchase Prices Continue to Rise Apple's CFO said on a conference call that pricing for memory purchases continues to increase. M impact | EQUITY | Nov 02, 2026, 10:40 PM UTC Calix Q3 Revenue Rises, Issues Q4 Guidance Calix reported higher Q3 revenue and issued Q4 guidance. M impact | EQUITY | Nov 02, 2026, 10:40 PM UTC Ero Copper Reports Q3 Production of 18,345 Tonnes in Concentrate Ero Copper reported consolidated Q3 copper production of 18,345 tonnes in concentrate and C1 cash costs of $2.51 per pound. M impact | EQUITY | Nov 02, 2026, 10:39 PM UTC Apple Extends Extended-Hours Drop, Down 3.96% at $324.92 Apple shares were last down 3.96% at $324.92 in extended trading. M impact | EQUITY | Nov 02, 2026, 10:38 PM UTC Boise Cascade Reports Higher Q3 Earnings and Sales Boise Cascade reported that Q3 earnings and sales rose. M impact | EQUITY | Nov 02, 2026, 10:38 PM UTC